Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Erlotinib-13C6 (CP-358774-13C6) is a 13C-labeled Erlotinib. Erlotinib is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 1,988.00 |
Description | Erlotinib-13C6 (CP-358774-13C6) is a 13C-labeled Erlotinib. Erlotinib is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR[1]. |
In vitro | Erlotinib effectively diminishes EGFR autophosphorylation in intact tumor cells, presenting an IC50 value of 20 nM, and is employed in treating non-small cell lung cancer[1]. Additionally, stable heavy isotopes of hydrogen, carbon, and other elements are integrated into drug molecules, primarily serving as tracers for quantification throughout drug development[2]. |
Synonyms | Erlotinib-13C6 |
Molecular Weight | 399.397 |
Formula | C22H23N3O4 |
CAS No. | 1211107-68-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Erlotinib-13C6 1211107-68-4 Erlotinib-13C-6 Erlotinib13C6 Erlotinib 13C6 inhibitor inhibit